Vanda Pharmaceuticals Inc. (LON:0LKB)
4.621
-0.039 (-0.83%)
At close: Aug 26, 2025
Vanda Pharmaceuticals Market Cap
Vanda Pharmaceuticals has a market cap or net worth of 205.57 million as of August 29, 2025. Its market cap has decreased by -11.50% in one year.
Market Cap
205.57M
Enterprise Value
-26.79M
Revenue
148.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.62
Market Cap Chart
Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from 119.67M to 205.57M, an increase of 71.79%. That is a compound annual growth rate of 2.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 28, 2025 | 205.57M | -7.86% |
Dec 31, 2024 | 223.09M | 17.04% |
Dec 29, 2023 | 190.61M | -45.08% |
Dec 30, 2022 | 347.09M | -46.23% |
Dec 31, 2021 | 645.56M | 22.64% |
Dec 31, 2020 | 526.37M | -20.35% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 185.59B |
HSBC Holdings | 167.41B |
Shell | 157.59B |
Unilever | 116.15B |
British American Tobacco p.l.c. | 94.23B |
Rolls-Royce Holdings | 87.64B |
Rio Tinto Group | 77.77B |
RELX PLC | 65.50B |